Template:Cardiomyopathy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(7 intermediate revisions by the same user not shown)
Line 181: Line 181:
|-  
|-  
!  
!  
|- bgcolor="PaleGoldenrod "
!


|- bgcolor="CadetBlue"
|- bgcolor="CadetBlue"
!
!
Case Studies
Guidelines
|-  
|-  
!
!
Line 190: Line 193:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Cardiomyopathy case study one|Case #1]]
[[Cardiomyopathy 2023 ESC Guideline Recommendations|2023 ESC Guideline Recommendations]]
|-  
|-  
!
|- bgcolor="PaleTurquoise"
!
!
|- bgcolor="PaleGoldenrod "
[[Cardiomyopathy 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy|2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy]]
|-
!
 
|- bgcolor="CadetBlue"
!
!
{{PAGENAME}} On the Web
Case Studies
|-  
|-  
!
|- bgcolor="LightGreen"
!
!
[[Cardiomyopathy Guidelines|Guidelines]]
|- bgcolor="PaleTurquoise"
!
[[Cardiomyopathy case study one|Case #1]]
|-  
|-  
!
!
|- bgcolor="LightGreen "
{{PAGENAME}} On the Web
!
 
 
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!

Latest revision as of 06:57, 13 November 2023